Pediatric and Neonatal Immunology
Neonates have an emerging immune system, which is basically dissimilar from adults as a result of originally living in a semi-allogeneic sterile environment which will be then being exposed to a microbial-rich surrounding, rendering newborns highly susceptible to the infections. The main constituent of immune protection moved from the mother to child is known as antibody. This will moved from the placenta to the fetus using the FcRn (neonatal Fc receptor). Antibody will also transmitted to the infant from breast milk.
Related Conference of Pediatric and Neonatal Immunology
April 16-17, 2026
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Pediatric and Neonatal Immunology Conference Speakers
Recommended Sessions
- Aging and Immunosenescence
- Bacterial Immunology
- Cancer Immunology and Immunotherapy
- Cell & Plant Biology
- Cell , Animal & Plant Biology
- Cell Biology
- Clinical Immunology & Current & Future Research
- Digital Health and Telemedicine in Allergy Care
- Emerging Infectious Diseases
- Environmental and Occupational Immunology
- Immune Regulation
- Immune System
- Immuno informatics & Systems immunology
- Immuno-Genetics
- Immunohistochemistry
- Immunological Aspects of Drug Allergies
- Immunology
- Immunometabolism
- Immunotherapy
- Nutritional Immunology
- OncoImmunology
- Pediatric and Neonatal Immunology
- Reproductive Immunology
- Therapeutic Antibodies
- Transplantation and Computational Immunology
- Vaccines & Immunization
- Virology and infectious diseases
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Epidemiology - European Immunology 2025 (Italy)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Neuroimmunology - European Immunology 2025 (Italy)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Viral Immunology - European Immunology 2025 (Italy)